CONFLICT MINERALS

Position Statement On Conflict Minerals
 

 


Abbott is committed to a supply chain that contributes to sustainable development and responsible sourcing.
 

Abbott complies with applicable laws wherever it operates, including the provisions of the Dodd-Frank Act that require companies to begin reporting on the use of conflict minerals as part of their annual disclosure to the U.S. Securities and Exchange Commission. Conflict minerals include tantalum, tin, tungsten and gold (also known as 3TGs).
 

Abbott is conducting due diligence to understand the use and source of 3TGs in our products across our complex global supply chain. Following guidelines developed by the Organization for Economic Cooperation and Development (OECD), we are identifying products and suppliers in scope, and sending questionnaires to key suppliers, utilizing the Conflict Minerals Reporting Template (CMRT) developed by the Conflict Free Sourcing Initiative. We also have developed standardized contract language that will require Abbott's suppliers to disclose the presence and source of conflict minerals in their supply chains.
 

Abbott is committed to having business relationships with suppliers who share the company's dedication to conducting business in a legal and ethical manner. As we move forward, Abbott will maintain processes designed to ensure that our suppliers comply with our policies, as well as all applicable laws and regulations. This process includes querying select suppliers on an annual basis, and taking further actions as necessary to identify 3TGs in our supply chain.
 


 

Abbott has filed a Form SD and Conflict Minerals Report with the U.S. Securities and Exchange Commission for the year ended December 31, 2015.

 

 

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?